Five Technologies for Detecting the EGFR T790M Mutation in the Circulating Cell-Free DNA of Patients With Non-small Cell Lung Cancer: A Comparison

Third-generation tyrosine kinase inhibitors (TKIs) were developed to overcome T790M-mediated resistance to earlier generations of epidermal growth factor receptor (EGFR)-targeted TKIs. We compared four well-established and one in-house method for the analysis of the EGFR T790M mutation in plasma cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yi-Lin, Lin, Chien-Chung, Yang, Shu-Ching, Chen, Wan-Li, Chen, Jian-Rong, Hou, Yi-Hsin, Lu, Cheng-Chan, Chow, Nan-Haw, Su, Wu-Chou, Ho, Chung-Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6646711/
https://www.ncbi.nlm.nih.gov/pubmed/31380273
http://dx.doi.org/10.3389/fonc.2019.00631

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6646711/
https://www.ncbi.nlm.nih.gov/pubmed/31380273
http://dx.doi.org/10.3389/fonc.2019.00631

Ejemplares similares